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ABSTRACT
HDAC6 is a tubulin deacetylase involved in many cellular functions
related to cytoskeleton dynamics, including cell migration and
autophagy. In addition, HDAC6 affects antigen-dependent CD4+ T cell
activation. In this study,weshow thatHDAC6contributes to thecytotoxic
function of CD8+ T cells. Immunization studies revealed defective
cytotoxic activity in vivo in the absence of HDAC6. Adoptive transfer of
wild-type or Hdac6−/− CD8+ T cells to Rag1−/− mice demonstrated
specific impairment in CD8+ T cell responses against vaccinia infection.
Mechanistically, HDAC6-deficient cytotoxic T lymphocytes (CTLs)
showed defective in vitro cytolytic activity related to altered dynamics
of lytic granules, inhibited kinesin-1–dynactin-mediated terminal
transport of lytic granules to the immune synapse and deficient
exocytosis, but not to target cell recognition, T cell receptor (TCR)
activation or interferon (IFN)γ production. Our results establish HDAC6
asaneffectorof the immunecytotoxic response that acts byaffecting the
dynamics, transport and secretion of lytic granules by CTLs.
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INTRODUCTION
Cytotoxic T lymphocytes (CTLs) are a specialized population of
CD8+ T cells that provides defense against virus-infected cells and
tumors. Naïve CD8+ T cells differentiate into CTLs upon antigen
recognition, a process involving the synthesis and storage of
cytotoxic mediators into lysosomal-derived lytic granules (Williams
and Bevan, 2007). CTLs eliminate target cells by different
mechanisms, including secretion of pro-inflammatory cytokines
[e.g. tumor necrosis factor (TNFα) or interferon (IFN)γ; de Saint
Basile et al., 2010] and FAS-L (FAS ligand; officially known as
FASLG) ligation to its receptor, as well as granule-mediated
apoptosis upon cell–cell contact and immune synapse formation
(Ritter et al., 2013). Lytic granules fuse with the plasma membrane
and release granzymes, cathepsins and perforins (Prf proteins)
(Lopez et al., 2013; Pardo et al., 2009). The immune synapse acts as
a focal point for exocytosis of lytic granules. Lytic granule
polarization towards the target cell depends on T cell receptor
(TCR) engagement, driven by the relocation of the centrosome to
immune synapse. The lytic granules degranulate at a secretory
domain adjacent to the TCR-enriched region within the immune
synapse (de Saint Basile et al., 2010; Ritter et al., 2013).
Histone deacetylase 6 (HDAC6) is a ubiquitous cytosolic
protein from the class II HDACs family with X-linked inheritance,
that binds to and deacetylates α-tubulin at Lys40 (Hubbert et al.,
2002; Valenzuela-Fernandez et al., 2008). HDAC6 also modulates
other substrates, for example, cortactin and Hsp90. HDAC6
controls cell migration (Zhang et al., 2007), T-regulatory functions
(de Zoeten et al., 2011) and CD4+ T cell activation (Serrador et al.,
2004). Consistent with this, HDACs inhibitors impair some
immune functions (Mosley et al., 2006; Tsuji et al., 2015).
However, the precise contribution in vivo (by using Hdac6−/−
mice) has not been assessed, and the mechanisms involved remain
unsolved. HDAC6 also functions as a scaffold protein in T cell
migration (Cabrero et al., 2006) and the transport of misfolded
proteins (Kawaguchi et al., 2003). In this report, we describe the
impaired killing capacity of Hdac6−/− CTLs. The molecular
mechanism underlying this defect involves a scaffold role that
positions HDAC6 as a protein that oversees the proper movement
of lytic granules, their transport to the immune synapse and
secretion towards the target cell.
RESULTS AND DISCUSSION
HDAC6 deficiency reduces the cytolytic capacity of CD8+
T lymphocytes
We examined the ability of cytotoxic T cells fromHdac6−/−mice to
kill target cells in vitro. CD8+ T cells from wild-type (WT) and
Hdac6−/− mice expressing the transgenic ovalbumin (OVA)-
specific TCR (OT-I) were activated in vitro and cultured to
generate CTLs. Cell cytotoxicity was subsequently analyzed by
survival of dye-labeled EL4 target cells pulsed or not with
OVA257–264 peptide (SIINFEKL). Hdac6
−/− CTLs showed
decreased killing activity (Fig. 1A), consistent with reduced
expression of CD107a (also known as LAMP1) in Hdac6−/−
CTLs upon degranulation (Fig. 1B). Likewise, CTLs from OT-I
mice treated with tubastatin A, a potent HDAC6 inhibitor (Butler et
al., 2010), displayed a reduced killing ability (Fig. S1A). We also
detected decreased Prf1 secretion from activated (i.e. induced by
anti-CD3 and anti-CD28 monoclonal antibodies) Hdac6−/− CTLs
(Fig. 1C, left). Next, we assessed the secretion promoted by
phorbol-12-myristate-13-acetate (PMA), to bypass TCR
stimulation. Both cathepsin D and Prf1 decreased in supernatants
from activated Hdac6−/− CTLs (Fig. 1C, right). Taken together, our
data demonstrate that Hdac6−/− CTLs show reduced cytotoxic
activity and suggest that HDAC6 controls exocytosis.Received 22 September 2015; Accepted 8 February 2016
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We next tested IFN-γ production; the frequency of CTLs
producing IFNγ and its secretion was unaffected in activated
Hdac6−/− CTLs (Fig. 1D,E), in contrast to what has been described
for ACY-1215, a recently described inhibitor that is tenfold more
selective for HDAC6 than for HDAC1, HDAC2 and HDAC3 (class
I HDACs) that shows slight activity against HDAC8 (Tsuji et al.,
2015). Likewise, treatment of CTLs from OT-I mice with tubastatin
A had no significant effect (Fig. S1B). Importantly, T cell signaling
induced by anti-CD3 and anti-CD28 monoclonal antibodies in
Hdac6−/− cells was comparable to control, as determined by
Fig. 1. See next page for legend.
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assessing PLCγ1 and Erk1 and Erk2 (Erk1/2; also known as
MAPK3 and MAPK1, respectively) phosphorylation (Fig. 1F).
Likewise, the increase in intracellular Ca2+ remained unchanged
upon activation (Fig. 1G). As expected, tubulin acetylation at Lys40
was increased in Hdac6−/− CTLs (Fig. 1F). These results suggest
that the killing defect observed does not result from a general
impairment of CTLs function.
Defective in vivo and ex vivo killing in HDAC6-knockout mice
The effector activity of Hdac6−/− CD8+ T cells was tested in vivo
following immunization of mice by inoculation with SIINFEKL-
pulsed dendritic cells. The in vivo killing activity against the
injected splenocytes as target cells (pulsed or not with SIINFEKL)
was analyzed upon recovery by peritoneal lavage. Notably,
Hdac6−/− mice showed reduced specific killing of target cells
(Fig. 2A, left panel). However, the proportion of SIINFEKL-
specific CD8+ T cells in the endogenous repertoire was not affected
in Hdac6−/− mice (Fig. 2A, right panel), suggesting that the
cytotoxic function rather than the number of antigen-specific CTLs
could underlie the defect. Next, we examined whether the decreased
cytotoxic function of the CTLs resulted in an impaired ability to
prevent morbidity and/or mortality during a viral infection. To
restrict HDAC6 deficiency to CD8+ T cells, we adoptively
transferred Rag1−/− mice with WT or Hdac6−/− naïve CD8+ T
cells and subsequently challenged with a fully replicative vaccinia
virus (VACV) WR strain. This infection model mimics the
immunological and clinical features of smallpox vaccination in
humans (Mota et al., 2011). CD8+ T cell proliferation was
comparable, or even increased (division 4) in Hdac6−/− mice
(Fig. 2B). Rag1−/− mice adoptively transferred with Hdac6−/−
CD8+ T cells showed increased morbidity at 9 and 11 days post-
infection (dpi) (Fig. 2C). Virus titration from the lesion tissue
demonstrated that Hdac6−/− immune cells exerted a less-efficient
virus clearance (Fig. 2D). Consistent with our findings on the lack of
effect in endogenous antigen-specific CD8+ T cell numbers, CTL
expansion tracked at 13 dpi was not affected in Hdac6−/− mice
(Fig. 2E, left). The proportion of activated CD8+ T cells (CD44high,
with high expression of CD44) at early (5 dpi) and late stages (13–
30 dpi) of the disease were similar for WT and Hdac6−/− mice
(tested in peripheral blood and spleen, respectively; Fig. 2E, right).
These in vivo results emphasize the role of HDAC6 in the CD8+ T-
cell-dependent protection against VACV infection without affecting
effector CD8+ CTL differentiation.
HDAC6 drives the terminal transport of lytic granules to the
target cell
CTL killing is limited to target cells (and not neighbor cells) by the
confinement of secretion to the immune synapse established
between the CTL and the target cell (de Saint Basile et al., 2010).
Interestingly, the intracellular colocalization between cathepsin D
and Lamp1 (CD107a) was affected in Hdac6−/− CTLs conjugated
with target cells, pointing to the mislocalization of lytic mediators in
these cells (Fig. 3A; images and middle graphs). The decreased
secretion of lytic proteins from Hdac6−/− CTLs suggests that
HDAC6 regulates exocytosis of lytic granules (Fig. 1C). Indeed, the
translocation of the centrosome to the contact areawith the target cell
was more pronounced inHdac6−/−CTLs than inWT cells (Fig. 3A,
right graph), in accordance with the effect described for the HDAC
inhibitor Trichostatin A on the centrosomal polarization in CD4+ T
cells (Serrador et al., 2004). This suggests that the defective
exocytosis might rely on the movement of lytic granules themselves.
We thus monitored the dynamics of lytic granules at the
subcortical immune synapse cytoskeleton and their release by
total internal reflection fluorescence microscopy (TIRFm). CTLs
were loaded with a pH-dependent lysosomal tracker, which allows
the visualization of the lytic granules, and settled on to a stimulating
surface to form an immune-synapse-like structure (Fig. 3B). These
experiments revealed significant changes in the distribution of the
lytic granules and their dynamics, with a marked decrease in the
number of lytic granules detected at the immune-synapse-like
structure in Hdac6−/− cells, suggesting alterations to the active
transport of the granules from the centrosomal region to the plasma
membrane. Indeed, the mean fluorescence intensity detected for
Hdac6−/− granules was lower, which suggests a higher pH and,
therefore, a different degree of maturation, although the lytic
granules displayed similar sizes inWTandHdac6−/− cells (Fig. 3C).
The most remarkable difference pertained to the x–y distribution
of the lytic granules, which was wider (diffusion surface) in the
Hdac6−/− CTLs, with a higher diffusion coefficient, although there
were similar duration times and path lengths (Fig. 3D). These data
suggest that the lytic granules fromHdac6−/− CTLs are not properly
targeted and/or that they dock inefficiently at the immune synapse.
Tubulin motors control the delivery of lytic granules to the plasma
membrane. Whereas dynein controls lytic granule targeting to the
centrosome (Burkhardt et al., 1993; Mentlik et al., 2010), the kinesin-
1–Slp3–Rab27a (Slp3 is also known as SYTL3) complex directs
terminal transport to the plasma membrane for exocytosis (Kurowska
et al., 2012). Dynactin might also be part of this complex, linking the
cargo to kinesin-1 motor (Haghnia et al., 2007; Hendricks et al.,
2010). We then hypothesized that HDAC6 regulates the movement
and delivery of the lytic granules at the immune synapse through
kinesin-1. Using a biochemical approach, we observed that HDAC6
formed a complex with kinesin-1 light chain (KLC1) upon triggering
Fig. 1. HDAC6 modulates the efficiency of target cell killing and
degranulation of lytic mediators. (A) Graph showing in vitro cytotoxic assay
for specific lysis of SIINFEKL-pulsed EL4 target cells by OT-I (OTI) WT or
Hdac6−/−CTLs. Mean±s.e.m. (n=5mice for each genotype) of specific lysis for
5 h are shown at the indicated target to effector ratios. All killing assays were
performed in triplicate. **P<0.01; ***P<0.001 (unpaired t-test). Histograms
show a representative FACS profile. (B) Degranulation is shown as the
percentage of CD107a+ cells detected by FACS in activated versus non-
stimulated WT and Hdac6−/− CD8+ CTLs. Results are mean±s.e.m.; n=5 for
each genotype. *P<0.05 (unpaired t-test). (C) Exocytosis of lytic mediators
upon T cell activation. Left, perforin content in culture cell supernatants as
determined by ELISA. CTLs were stimulated with anti-CD3, and anti-CD28
monoclonal antibodies and goat anti-Armenian-hamster IgG antibodies (5 h).
Graphs show mean±s.e.m. (n=6 mice for each genotype). *P<0.05 (unpaired
t-test). Middle panel, representative western blot showing exocytosis. PMA
stimulation was for 1 h. Normalization was performed against cell fractions.
Right graphs, quantification of the experiments (mean±s.e.m.; three
independent experiments). (D) IFNγ secretion in supernatants from WT and
Hdac6−/− CTLs activated by anti-CD3 and anti-CD28 monoclonal antibodies
as determined by ELISA. Results are mean±s.e.m.; n=3 for each genotype;
Mann–Whitney test. (E) Percentage of IFNγ+ cells in WT and Hdac6−/− CTLs
activated by activated by anti-CD3 and anti-CD28 monoclonal antibodies.
Results are mean±s.e.m.; n=6 (0 and 6 h) and n= 3 (4 h) for each genotype;
Mann–Whitney test. (F) Effector CD8+ CTLs isolated from WT and Hdac6−/−
mice were activated (by anti-CD3 and anti-CD28 monoclonal antibodies),
lysed and blotted for PLCγ (pY783) and Erk1/2 (pT202/Y204)
phosphorylation, and tubulin acetylation (acet). (G) Ca2+ flux. WT and
Hdac6−/−-purified CTLs pre-loaded with the INDO-1 AM probe were analyzed
for free and bound Ca2+ by flow cytometry. Left graphs, time course of
ratiometric variation (left y axis); black line, median activation as normalized to
basal levels (0%) and total activation by ionomycin treatment (100%; right y
axis). Stimuli are indicated. A representative experiment is shown. Right graph,
mean±s.d. of the increase in the ratio (WT, n=7; Hdac6−/−, n=6). ns, not
significant (Mann–Whitney test).
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Fig. 2. In vivo function of CTLs is impaired in HDAC6 knockout mice. (A) WT and Hdac6−/− were immunized against SIINFEKL peptide. 7 days after
immunization, Cell-Violet-labeled target cells that had been SIINFEKL-pulsed (1 μM) or not were injected intraperitoneally, and recovered through intraperitoneal
lavage (24 h). Cell survival assessed by FACS (left panel). Data represent mean±s.e.m. n=12 for each genotype from three independent experiments. *P<0.05,
Mann–Whitney test. The relative percentage of CD8+ H-2Kb+ cells was determined to control avidity towards SIINFEKL (right panel, results aremean±s.e.m.;WT,
n=10; Hdac6−/−, n=9 from three independent experiments; Mann–Whitney test.) (B) Proliferation of CD8+ cells in VACV-OVA-infected WT and Hdac6−/− mice.
Results aremeans±s.e.m. (n=5 for each genotype); **P<0.01 (Mann–Whitney test). (C)Rag1−/−mice inoculated intravenously with 0.8×106 CD8+ naïve cells and
infected with VACV-WR through tail scarification were weighed every 2 days. Results are means±s.e.m. (n=10 for each genotype). **P<0.01 (Mann–Whitney
test). (D) Titration of viral particles from scarified tails (13 dpi). The colonies of CV-1 cells infected in vitrowith different dilutions of tail extracts were counted, and
normalized to the tail tissue weight. Results are means±s.e.m. (WT, n=13; Hdac6−/−, n=14); *P<0.05 (Mann–Whitney test). (E) Percentage of CD8+ expansion
and CD44 expression by FACS analysis in peripheral blood (5 dpi) and in spleen populations (13 and 30 dpi). CD11b was used as negative control. Results are
means±s.e.m. (n=5; Mann–Whitney test).
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with anti-CD3 and anti-CD28 monoclonal antibodies (Fig. 3E).
Moreover, interaction of the kinesin-activator complex dynactin
subunits p150-glued (also known as DCTN1) and p50-dynamitin
(also known as DCTN2) was impaired in Hdac6−/− (Fig. 3F).
In summary, our data support a specific role for HDAC6 in the
intracellular localization of lytic mediators and, particularly, in their
exocytosis. Therefore, the catalytic and scaffold activities of
HDAC6 might act at multiple levels in the control of cytotoxic-
related pathways, making HDAC6 a potential candidate that could
be targeted to modulate CTLs in specific diseases.
MATERIALS AND METHODS
Mice
Hdac6−/− micewere generated through targeting of exons 10 to 13 (Gao et al.,
2007). Theywere intercrossed in aC57BL/6 background to generatewild-type
and knockout littermates. Mice presenting transgenic inserts for mouse
Fig. 3. HDAC6 drives the terminal transport of lytic granules to the target cell. (A) Confocal microscopy images of WT and Hdac6−/− OT-I-derived CTLs
conjugated with 7-amino-4-chloromethylcoumarin (CMAC)-loaded, OVA-pre-pulsed target EL4 cell (500 nM SIINFEKL, cyan) for 15 min. Green, CD107a; red,
cathepsin D; magenta, α-tubulin. Bright-field (BF) images correspond to a unique plane, and fluorescence images correspond to maximal projections from
z-stacks. Middle graphs, Manders’ coefficient for colocalization of Lamp1 and cathepsin D. Results are mean±s.e.m. (WT, n=39; Hdac6−/−, n=35). ***P<0.001
(Mann–Whitney test). Right graph, quantification (mean) of microtubule-organizing center (MTOC) translocation (n>270, from three independent experiments).
*P<0.05 (unpaired t-test). (B) Representative TIRFm images of Lysotracker-Red-loadedWT and Hdac6−/−CTLs in glass-bottom chambers coated with anti-CD3
and anti-CD28 monoclonal antibodies. Video recording was initiated upon cell adhesion (37°C and 5% CO2). Images were acquired for 5 min every 0.5 s.
(C,D) Quantification for lytic granules parameters at the immune-synapse-like structure was performed for each cell (n=28 for each genotype, three independent
experiments). Results are mean±s.e.m. (n=28 for each genotype). *P<0.05; **P<0.01 (Mann–Whitney). (E,F) Western blots showing immunoprecipitates (IP)
from resting or activatedWT andHdac6−/−CTLs (15 min) from a representative experiment out of three. Anti-KLC1 (E) or anti-p150 glued (p150) antibodies were
used (F). Samples were blotted against indicated antibodies. Ab, pre-immune control antibody. Scale bars: 4 µm.
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Tcra-Variable2 and Tcrb-Variable5 genes, which TCR recognizes
ovalbumin257-264 peptide in the context of H2Kb MHC-I (OT-I) were
crossed to female Hdac6+/−mice to generate WT and KO littermates; males
were used for in vivo experimentation given that Hdac6 is an X-linked gene.
Rag1−/−micewere used for adoptive transfer experiments. These studies were
approved by the local Ethics Committee for Basic Research at the CNIC and
the Comunidad Autónoma de Madrid.
Cell culture
Cytotoxic cells were produced by culturing cells upon stimulation with
SIINFEKL peptide (0.5 µM, 24 h) or concanavalin A (2.5 µg/ml, 36 h) and
cultured in presence of IL-2 (50–100 IU/ml) for at least 7 days. All other
cells were cultured and treated as described previously (Cascio et al., 2015;
Martín-Cófreces et al., 2006; Sancho et al., 2008).
Immunoprecipitation, CTL signaling and immunoblotting
Experiments were performed as described previously (Martín-Cófreces
et al., 2012, 2008, 2006); anti-KLC1 antibody was from Merck Millipore
(Darmstadt, Germany; KLC; at 5 μg/ml for immunoprecipitation and 1 μg/ml
for western blotting), anti-HDAC6 (at 0.1 μg/ml for western blotting) from
Assay Biotech (Sunnyvale, CA), and anti-p50 and -p150 from BD
Pharmingen (Franklin Lakes, New Jersey, US; anti-p150 was used at
1 μg/ml for immunoprecipitation and 0.25 μg/ml for western blotting. Anti-
p50 at 0.25 μg/ml for western blotting).
Measurement of intracellular variations in Ca2+ levels by using
flow cytometry
The method used for intracellular Ca2+ influx has been described previously
(June andMoore, 2004). In particular, 5×106 purified CD8+ CTLs generated
in vitro were loaded with 2 µg ml−1 INDO-1 AM (Invitrogen Corporation)
and stimulated with anti-CD3 and anti-CD28 monoclonal antibodies (BD
Biosciences; Franklin Lakes, NJ) plus goat anti-Armenian-hamster IgG
antibodies (Jackson Immunoresearch Laboratories; West Grove, PA; 6, 3
and 6 µg/ml, respectively).
In vitro degranulation assay
CD107a expression was monitored with Alexa-Fluor-647-conjugated anti-
CD107a antibody (BD Biosciences) in monensin-pretreated CD8+ OT-I cells
(5 mM) stimulatedwith SIINFEKL-pulsed (1 µM; 3 h, 37°C) EL4 cells. Cells
were stained with phycoerythrin-conjugated anti-CD8 and FITC-conjugated
anti-CD44 antibody, analyzed by fluorescence-activated cell sorting (FACS)
and data were processed with FlowJo 7.6.5 (TreeStar Inc, Ashland, OR).
Confocal and total internal reflection fluorescence microscopy
analysis
Cell conjugates between CTLs and EL4 cells were allowed to form (15 min)
and processed as described previously (Cascio et al., 2015; Martín-Cófreces
et al., 2006) under a Leica SP5 confocal microscope (Leica Microsystems;
Mannheim, Germany) mounted on an inverted DMI6000 microscope fitted
with a HCX PL APO 63×1.40-0.6 NA oil objective. Images were processed
using Imaris software (Bitplane; Zurich, Switzerland) and Image J software
(http://rsbweb.nih.gov/ij/), and assembled with Photoshop 6 software. The 3D
distance from the centrosomal center of mass to the target cell-edge was
measured by generating image masks from fluorescence with Imaris Software.
TIRFm imaging was performed with a Leica AM-TIRF-MC-M system
mounted on a Leica DMI-6000B microscope coupled to an Andor-
DU8285_VP-4094 camera (Andor; Belfast, UK) fitted with a HCX-PL-APO
100.0×1.46 NA oil objective as described previously (Baixauli et al., 2011;
Martín-Cófreces et al., 2012). The laser penetrance used was 90 nm (561 nm
laser). The mechanical properties of the lytic granules were determined
with a user-customized routine developed in Python. The software can
be freely downloaded from: https://dl.dropboxusercontent.com/u/4050954/
VesiclesAnalyser.zip. For more information, see the tutorial included.
Vaccinia virus infection and virus titration
Tails were scarified with vaccinia virus [VACV; 2×106 plaque-forming units
(PFU)/mouse] by gently scratching (×25) with a 28 1/2 G needle. For virus
titration, tails were mechanical disaggregated (1 ml of PBS), subjected to
freeze-thaw cycles and sonication. Serial dilutions of the homogenates were
added to monolayers of CV-1 cells seeded in 24-well plates. Cells were
stained with Cristal Violet 24 h later. We observed a detection limit of 5
PFU/tail, the number of plaques was multiplied by the reciprocal of sample
dilution and converted to PFU/g of tissue.
In vitro and in vivo cytotoxicity assay
For in vitro experiments, EL4 target cells were incubated with 1 μM Cell
Violet and pulsed with 1 μMSIINFEKL, or with 0.1 μMCell Violet and no
SIINFEKL, washed extensively, mixed (1:1), pooled with different
dilutions of effectors, plated in a 96-well U-bottomed plate for 5 h (37°C)
in triplicate and analyzed by FACS. Dead cells were excluded on the basis of
propidium iodide staining. The mean percentage of survival in antigen-
loaded targets was calculated relative to antigen-negative internal controls in
each sample. Specific lysis was calculated by using the following equation:
percentage specific lysis=100×[1−(percentage of cells staining for Cell
Violet at 1 µM/percentage of cells staining for Cell Violet at 0.1 µM)]. All
data were normalized to the basal specific lysis in absence of effector cells.
For in vivo assays, WT and Hdac6−/− mice were inoculated by
intraperitoneal injection of bone marrow dendritic cells pulsed with 1 µM
of SIINFEKL and lipopolysaccharide (LPS; 1 µg ml−1) for 1 h. After
7 days, CD45.1 splenocytes were prepared as targets as described above and
injected intraperitoneally into recipients. Cells were recovered 24 h later by
peritoneal lavage and in vivo killing levels measured (Hermans et al., 2004;
Iborra et al., 2012; Sancho et al., 2008; Schulz et al., 2005).
Statistical analysis
Data were analyzed with GraphPad Prism software (La Jolla, CA) for
normality (D’Agostino-Pearson or the Kolmogorov–Smirnov test for small
samples). Student’s t-tests or Mann–Whitney tests were used for normal or
non-normal data, respectively, and two-tailed ANOVA for grouped data
(Bonferroni post-test).
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